Rotarix vaccine oral syringe 1.5ML
Ended Awarded
- Contract number
- SPE2DB26FV3W1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,848
Award facts
- Contract value 100% obligated
- $5,848.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,848.24 by the Defense Logistics Agency (DLA) for the supply of Rotarix vaccine in oral syringe format (1.5 mL). The contract was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, and utilizes firm fixed pricing with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the DLA, supplying a comprehensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. All of the company's reviewed contract awards have been competitively awarded without set-aside designations, demonstrating its capability to meet federal procurement requirements through open competition. This Rotarix vaccine delivery order represents a routine fulfillment under the company's established relationship with the DLA for supporting federal healthcare supply chains.
Quick answers
Who was awarded contract SPE2DB26FV3W1?
SPE2DB26FV3W1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FV3W1 worth?
The government has obligated $5,848 on SPE2DB26FV3W1.
Is contract SPE2DB26FV3W1 an order under another contract?
Yes. SPE2DB26FV3W1 is a delivery order under SPE2DB20D3104, an indefinite delivery contract.
Was contract SPE2DB26FV3W1 competed?
The extent of competition for SPE2DB26FV3W1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award